Trial intelligence / Profile preview

Safety and Immunogenicity of Two DTaP-IPV Vaccines in Healthy Children

NCT00655148Phase 3Completed

Sponsor
Statens Serum Institut
Start
Sep 2003
Primary completion
Oct 2006
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of diphtheria toxoid + tetanus toxoid + acellular pertussis + inactivated poliovirus vaccine in diphtheria, Tetanus, pertussis, poliomyelitis, sponsored by Statens Serum Institut. Started Sep 2003; status: completed.

02

Drugs

diphtheria toxoid + tetanus toxoid + acellular pertussis + inactivated poliovirus vaccine
03

Conditions

diphtheriaTetanuspertussispoliomyelitis

Beyond the preview

Go deeper on NCT00655148.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00655148.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call